First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Hormone Receptor Positive Breast Cancer|Triple Negative Breast Cancer|Non-small Cell Lung Cancer
Interventions: DRUG: Datopotamab Deruxtecan (Dato-DXd)|DRUG: Steroid Containing Mouthwash|OTHER: Non-Steroid Containing Mouthwash
Sponsor: Daiichi Sankyo Co., Ltd.
Collaborators: Daiichi Sankyo|AstraZeneca